Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.18B |
| 2 |
Apple
AAPL
|
+$1.11B |
| 3 |
Broadcom
AVGO
|
+$562M |
| 4 |
Amazon
AMZN
|
+$553M |
| 5 |
Palo Alto Networks
PANW
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$246M |
| 2 |
O'Reilly Automotive
ORLY
|
+$149M |
| 3 |
Cadence Design Systems
CDNS
|
+$149M |
| 4 |
Synopsys
SNPS
|
+$134M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.24% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Arcus Biosciences
RCUS
$3.48B
| $20.9M | ﹤0.01% |
1,028,922
+50,755
| +5% | +$966K |
|
1827
Medifast
MED
$137M
| $20.9M | ﹤0.01% |
226,377
+5,303
| +2% | +$472K |
|
|
SASR
1828
DELISTED
Sandy Spring Bancorp Inc
SASR
| $20.8M | ﹤0.01% |
918,102
+34,140
| +4% | +$783K |
|
|
PLYM
1829
DELISTED
Plymouth Industrial REIT
PLYM
| $20.8M | ﹤0.01% |
903,046
+73,873
| +9% | +$1.58M |
|
1830
Core Laboratories
CLB
$502M
| $20.8M | ﹤0.01% |
893,278
+464,644
| +108% | +$10.5M |
|
1831
Helix Energy Solutions
HLX
$1.37B
| $20.7M | ﹤0.01% |
2,808,433
+114,582
| +4% | +$815K |
|
|
RTL
1832
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $20.7M | ﹤0.01% |
3,063,687
+51,469
| +2% | +$305K |
|
|
HAPN
1833
Happen Inc
HAPN
$2.36B
| $20.7M | ﹤0.01% |
2,119,723
+103,878
| +5% | +$834K |
|
1834
Treace Medical Concepts
TMCI
$310M
| $20.7M | ﹤0.01% |
807,708
+113,445
| +16% | +$2.93M |
|
1835
Lifestance Health
LFST
$3.96B
| $20.6M | ﹤0.01% |
2,261,394
+429,132
| +23% | +$3.57M |
|
1836
Seadrill
SDRL
$2.6B
| $20.6M | ﹤0.01% |
+500,155
| New | +$18.6M |
|
|
ETWO
1837
DELISTED
E2open Parent Holdings
ETWO
| $20.6M | ﹤0.01% |
3,684,909
+121,930
| +3% | +$655K |
|
1838
Chegg
CHGG
$115M
| $20.6M | ﹤0.01% |
2,318,387
-23,841
| -1% | -$289K |
|
1839
Navitas Semiconductor
NVTS
$3.22B
| $20.5M | ﹤0.01% |
1,944,227
+1,045,279
| +116% | +$8.09M |
|
1840
FIGS
FIGS
$1.82B
| $20.5M | ﹤0.01% |
2,476,483
+112,110
| +5% | +$852K |
|
1841
Viridian Therapeutics
VRDN
$2.33B
| $20.5M | ﹤0.01% |
860,857
+84,745
| +11% | +$2.17M |
|
1842
Hope Bancorp
HOPE
$1.82B
| $20.4M | ﹤0.01% |
2,428,074
+82,929
| +4% | +$724K |
|
1843
AMERISAFE
AMSF
$558M
| $20.4M | ﹤0.01% |
383,152
+3,968
| +1% | +$211K |
|
|
CBAY
1844
DELISTED
Cymabay Therapeutics
CBAY
| $20.3M | ﹤0.01% |
1,855,470
+950,512
| +105% | +$8.85M |
|
|
CSR
1845
Centerspace
CSR
$956M
| $20.3M | ﹤0.01% |
331,088
+5,500
| +2% | +$322K |
|
1846
ZipRecruiter
ZIP
$346M
| $20.3M | ﹤0.01% |
1,143,874
+15,045
| +1% | +$248K |
|
|
ARR
1847
Armour Residential REIT
ARR
$2.35B
| $20.3M | ﹤0.01% |
759,990
+146,339
| +24% | +$3.73M |
|
1848
Amylyx Pharmaceuticals
AMLX
$2.43B
| $20.2M | ﹤0.01% |
937,997
+47,015
| +5% | +$1.27M |
|
|
PYCR
1849
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $20.1M | ﹤0.01% |
851,179
-6,708
| -0.8% | -$156K |
|
|
ADAM
1850
Adamas Trust
ADAM
$848M
| $20.1M | ﹤0.01% |
2,030,699
-33,785
| -2% | -$335K |
|
Similar funds
Geode Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
- Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
- Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
- Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
- Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.